Igniting our potential Health Research Classification System: Coder Training Course November 2015 Dr. James Carter, MRC.

Slides:



Advertisements
Similar presentations
Mental health strategy of the Medical Research Council (UK) Opportunities for European engagement and a role of FEAM European Parliament 22 nd March 2011.
Advertisements

Implementing NICE guidance
Cancer Registration and Health Service Regulation Dr Jenifer A E Smith.
Introduction to the unit and mixed methods approaches to research Kerry Hood.
UK Clinical Research Network (UKCRN) UK Clinical Research Network Maxine Stead PhD UKCRN Assistant Director – Clinical Trials.
Towards a New R&D Strategy A blueprint for R&D in Health and Social Care Noreen Caine Deputy Director of R&D, DH NHS R&D Forum Annual Conference May 2005.
Interpreting the Commissioning for Value Packs
Informing the Strategy – Strengths and Gaps Delyth Morgan Strategic Research Coordinator Cardiff University, School of Medicine.
L1:Apply the concepts of health and wellness to identify health behaviours and factors influencing choice and change in health using an holistic approach.
AcoRD Implementation Amber O’Malley, CRN Funding and Contracts Manager & AcoRD Business Lead.
NICE and NICE’s equality programme in 2012 Nick Doyle Clinical and public health analyst.
Quick wins in research Collaboration between clinical and academics Faculty of Health Sciences: MSK Cluster/ Rehabilitation and Health Technologies.
The Key Role of Charities in Supporting Brain Research Marie Downes, MRCG Development Executive Brain Research in Ireland: Delivering on the Potential.
Update on a recently launched European R&D endeavour: The Innovative Medicines Initiative (IMI) FERS meeting Brussels, 7 th April 2008.
Level Health Equally Well Key findings from a literature review informing collaborative efforts to improve the physical health outcomes of people with.
Janet Darbyshire (25 June 07) UK Clinical Research Network (UKCRN) Identifying research priorities in the UK Clinical Research Network.
Therapeutic exercise foundation and techniques Therapeutic exercise foundation and concepts Part II.
Health and Wellbeing Health Service Executive Healthy Ireland – The policy context for addressing health inequalities in Ireland Dr. Stephanie O’Keeffe,
Chronic Disease A Public Health Perspective. Chronic Disease Overview The most prevalent, costly, and preventable chronic diseases –cardiovascular disease.
Integration, cooperation and partnerships
Chronic Disease A Public Health Perspective Ronald Fischbach, Ph.D.
Diabetes Programme Progress Report Dr Charles Gostling, Joint Diabetes Clinical Director October 2013.
Course 17: Neglected Tropical Diseases & NCDs 9 th GA of IAPB Hyderabad; 19 th September 2012 NCDs & Eye Health Converging interests and opportunities.
The Chief Scientist Office. Developments/Restructuring Of Research Funding In Scotland Overview of NHS Infrastructure funding ( ) What we have.
ORIENTATION SESSION Strengthening Chronic Disease Prevention & Management.
Navigating the Cochrane Clinical Answers website.
Development of Clinical Practice Guidelines for the NHS Dr Jacqueline Dutchak, Director National Collaborating Centre for Acute Care 16 January 2004.
AHPs an integral part of the public health workforce Linda Hindle, Allied Health Professions Lead.
Needs Assessment: Young People’s Drug and Alcohol Services in Edinburgh City EADP Children, Young People and Families Network Event 7 th March 2012 Joanne.
Dr David Jackson Clinical Lead for Research YCRN Co-director WYCLRN Yorkshire Palliative Medicine Regional Learning Group April 2008 Clinical Research.
Who are they? Archie Cochrane The Cochrane Collaboration Formed in ,000+ people in 80+ countries 50 Collaborative Review Groups 12 Centres, Fields,
Alzheimer’s Society, UK Our research programme
NHPA’s. What are they? National Health Priority Areas (NHPAs) are diseases and conditions chosen for focused attention at a national level because of.
Lymphoedema Management: the Northern Ireland Model Jane Rankin Regional Lead Lymphoedema Network Northern Ireland (LNNI) February 2010.
Igniting our potential UK Health Research Analysis 2014.
American Evaluation Association EVALUATION 2009 November 14, 2009 Building Data Systems to Support Evaluation in a Biomedical Research and Development.
Igniting our potential Health Research Classification System Dr. Ian Viney Medical Research Council (MRC) Director of Strategic Evaluation and Impact MRC.
ARRA and HHS Data Policy Initiatives Academy Health NAHDO All Payer All Claims Data Bases James Scanlon, HHS Deputy Assistant Secretary/ASPE.
Better Evidence for a Better Start the social research unit at dartington.
Transforming Community Services Commissioning Information for Community Services Stakeholder Workshop 14 October 2009 Coleen Milligan – Project Manager.
Program 1 Healthy Start, Healthy Life. ‘To enhance the effective implementation of evidence-based techniques, tools and resources that support the delivery.
Igniting our potential From Donation to Innovation: An analysis of health research funded by medium and smaller sized medical research charities.
Public Health Preventive Medicine and Epidemiology Prof. Ashry Gad Mohammed MB, ChB. MPH, Dr P.H Prof. of Epidemiology College of Medicine King Saud University.
Presentation/Phenotype
The ERA-NET TRANSCAN-2, in continuity with the preceding ERA-NET TRANSCAN, aims at linking translational cancer research funding programmes in 15 Member.
How are priority issues for Australia's health identified? IDENTIFYING PRIORITY HEALTH ISSUES.
Anne Foley Senior Advisor, Ministry of Health New Zealand Framework for Dementia Care.
The Implementation Plan for Rare Diseases in Scotland abcdefghijklmnopqrstuabcdefghijklmnopqrstu.
Enhanced Primary Care Mental Health Service. External Drivers MH identified as a priority in the strategic commissioning plans for the 3 Worcestershire.
GENOMICS TO COMBAT RESISTANCE AGAINST ANTIBIOTICS IN COMMUNITY-ACQUIRED LRTI IN EUROPE (GRACE) H. Goossens (Coordinator), K. Loens (Manager), M. Ieven.
R&D Report to SL&M Board 17 September 2002 Graham Thornicroft Director of Research & Development Gill Dale Research & Development Manager.
Comparative Effectiveness Research (CER) and Patient- Centered Outcomes Research (PCOR) Presentation Developed for the Academy of Managed Care Pharmacy.
National Child and Maternal Health Intelligence Network Kate Thurland, National Child and Maternal Health Intelligence Network Public Health England.
NIHR Southampton Biomedical Research Centre The Southampton Biomedical Research Centre is funded by the National Institute for Health Research (NIHR) and.
Coming Soon – the MRC Framework for the Development, Design and Analysis of Stratified Medicine Research Dr David Crosby MRC Programme Manager for Methodology.
Chronic Disease A Public Health Perspective. Chronic Disease Overview The most prevalent, costly, and preventable chronic diseases –cardiovascular disease.
National Cancer Peer Review Programme NUSG Meeting 6 December 2012.
National Stroke Audit Rehabilitation Services 2016
Translational Research Methodology
American Evaluation Association
UK Health Research Analysis 2014
Presentation Developed for the Academy of Managed Care Pharmacy
The guiding principles of prudent healthcare
UK Health Research Analysis
Health and Social Services in the Department of Health
The MSK-HQ Developing a generic Musculoskeletal Patient Reported Outcome Measure Policy & Public Affairs Team, Arthritis Research UK e.
UKCRC Public Health Research Centres of Excellence
How will the NHS Long Term Plan work in our community?
Internal and External Quality Assurance Systems for Cycle 3 (Doctoral) programmes "PROMOTING INTERNATIONALIZATION OF RESEARCH THROUGH ESTABLISHMENT AND.
Dr Timothy Armstrong Coordinator
Presentation transcript:

Igniting our potential Health Research Classification System: Coder Training Course November 2015 Dr. James Carter, MRC

Structure of the Presentation  Background (40 mins)  Where the HRCS came from  What impact it has had  Who is using it now  Understanding the System (30 mins)  How the HRCS is structured  What it can and cannot do  How to use it in practice

Igniting our potential Health Research Classification System Background

UKCRC Partners

UK Health Research Analysis  Aim - Develop a coherent approach to funding health research  Up until then no national picture of UK health research  Evidence base of current funding patterns  Analysis conducted by UKCRC Secretariat on behalf of funders to map UK Health research portfolio

Adopted an approach based on cancer experience  National Cancer Research Institute  Partnership of government, charity and industry  Strategic Analysis 2002  Overview of UK cancer research  Based on Common Scientific Outline  Major outcomes  Joint strategy discussions  National Prevention Research Initiative  International Cancer Research Partnership (ICRP)

Organisations Participating  Government funding bodies  Health Departments (England, Scotland, Wales, N.Ireland)  MRC  ESRC, EPSRC, BBSRC (health or ageing relevant data)  Three largest charities  Wellcome Trust  Cancer Research UK  British Heart Foundation

Methodology  Established a central UKCRC Research Database  9638 UK-based directly funded peer reviewed health research awards (programmes, projects, training etc)  Awards ‘live’ between 1st April st March 2005  Designed a bespoke Health Research Classification System (HRCS)  Research Activity Codes – types of research  Health Categories – areas of health and disease  Labour intensive quality control led coding process

Proportion of Combined Total Spend by Research Activity

Proportion of Combined Total Spend by Research Activity – Kite Diagram

Profile of Each Organisation’s Spend by Research Activity

Proportion of Combined Spend on Health Specific Categories

From Donation To Innovation  29 medium & smaller sized AMRC member charities  1496 awards  Published 2007  Two reports together represent majority of UK government & medical research charities’ funding (over £1 billion funding)

Distribution of Total Spend by Research Activity

Impact of the Analyses and HRCS  Reports widely distributed  Evidence base used by  Individual funders  Joint planning and coordination  Research community  Classification system adopted by many UK government and charity funders  Primary data source for Cooksey Review

Inter-Analysis Period ( )  Change to Funder-Led Process  Health Research Analysis Forum (HRAF)  Chair/Lead Organisation: MRC  International Workshop 2009  EMRC recommendation for international adoption  Early development of auto-coding procedures – Elsevier Team

UK Health Research Analysis 2009/2010  Participants  Original 11 funders, plus Arthritis Research UK  Limited Budget  Funder led = in-house coding  Provision for external (contract) coding  BUT no quality control  Analysis (2009/2010)  12,000 awards with £1.6bn (~50% real terms increase)  New: Infrastructure Assessment, additional £827m  New: Estimation of Total UK Health Research Expenditure

Proportion of Combined Total Spend by Research Activity (2009/2010)

UK Health Research Analysis 2014: Aims  Improve speed of report production  Greater availability of data in more easily extracted format  The majority of awards already coded  Increase number of participating organisations  More medium/small charities and other public funders  Improve consistency and quality of coding  Review HRCS, update guidance and standardise approach  Make the data openly accessible  Considerable interest in further use of UK HRA data  Pre-agreement of HRAF members to release full public dataset

2014 Results – Total Analysis Spend  Increased participation (64 funders)  17,021 awards - £3.01bn spend  ~£2bn on direct awards (‘projects’)  ~£1bn on indirect awards (‘infrastructure’)  Increase in 5 and 10 year reporting  Rate slowing (CAGR 8.2% 04-09, 1.4% 09-14)

2014 Results – Health Categories

2014 Results – Research Activities

2014 Results – Charity / Public Distribution

Future of HRCS  Continue working to International Standard  Improve Coding Reliability  Increase reporting efficiency (auto-coding)  Begin plans for next analysis…?

Igniting our potential Health Research Classification System Understanding the System

What is the HRCS?  A system for classifying and analysing health and biomedical research funding  Designed collaboratively by a range of funders for the following purposes:  To cover the full spectrum of all types of research across all areas of health and disease  To provide a single stable common system allowing meaningful comparisons across time and between different portfolios  To answer strategic questions about investment  To give a “broad brush” overview of funding patterns

Structure of the HRCS  Two dimensional system  Health Categories  Research Activity Codes  Health Categories  All areas of health or disease  21 individual categories  Based on WHO International Classification of Diseases  Research Activity Codes  All types of research activity from basic to applied  48 codes in 8 groups  Based on cancer Common Scientific Outline

Key Features of the HRCS  Coding is based on the main research objective  Not a keyword system  Does not capture all potential downstream outcomes  Complements existing coding systems  Fit for purpose  Coding is linked directly to associated funding  Codes based on lifetime of the award  Exact percentages with every code  But is not a financial audit tool  System provides a broad overview of the centre of gravity of research  An aggregate population summary  Fine grained expertise not required

Key Aspects of HRCS Coding Process  Tried and Tested  Accumulated experience began in 2005  Several major analyses, thousands of awards  Range of organisations, award types and settings  Stable and Consistent  HRCS is openly available but not for alteration  Simple reproducible rules – equal proportions, minimum number of codes  Value lies in ability to compare over time and between settings

HRCS Online website  Makes all existing information and resources accessible  Overarching aim to promote sustainability of the system  Guidance for naïve users wanting to learn how to use the system  Reference source for experienced users  Provides further contextual help, summaries and linkages

Health Categories  Blood  Cancer  Cardiovascular  Congenital Disorders  Ear  Eye  Infection  Inflammatory and Immune System  Injuries and Accidents  Mental Health  Metabolic and Endocrine  Musculoskeletal  Neurological  Oral and Gastrointestinal  Renal and Urogenital  Reproductive Health and Childbirth  Respiratory  Skin  Stroke  Generic Health Relevance  Other

Notes on Health Categories (1)  Cancer  all types - not coded by site e.g. lung cancer  Cardiovascular  includes atherosclerosis  Congenital Disorders  multiple syndromes - excludes single focus syndromes like congenital heart disorders  Infection  all types - not coded by site e.g. respiratory tract infections  Inflammatory and Immune System  about immune system (not just immune response) - includes rheumatoid arthritis  Mental Health  includes normal behavioural and cognitive function – and all abnormal conditions defined by behaviour

Notes on Health Categories (2)  Musculoskeletal  includes osteoarthritis  Neurological  about brain function and ‘wiring’ – includes BSE and dementias  Reproductive Health and Childbirth  includes all aspects of pregnancy and the new born  Respiratory  includes asthma

Notes on Health Categories (3)  Generic Health Relevance  all areas of health or general health  Or >5 Health Categories  Other  A few very specific areas including Gulf War syndrome and chronic fatigue syndrome  Not a dustbin category  Note: Each category includes normal/healthy and disease processes  Note: Categories are not always deducible from causation, symptoms, or site of action

Guidance Topics on Health Categories See specific guidance on:  Sequelae  When a condition is a consequence or side effect of a pre-existing condition  If double coding, does one code make sense without the other?  Multiple diseases and conditions  Health category list for use in four areas – Alcohol; Diet / nutrition; Physical activity / exercise; Tobacco / smoking  Use only in the absence of other information

Overview of Research Activity Code Groups 1Underpinning Research Research that underpins investigations into the cause, development, detection, treatment and management of diseases, conditions and ill health 2Aetiology Identification of determinants that are involved in the cause, risk or development of disease, conditions and ill health 3 Prevention of Disease and Conditions, and Promotion of Well-Being Research aimed at the primary prevention of disease, conditions or ill health, or promotion of well-being 4 Detection, Screening and Diagnosis Discovery, development and evaluation of diagnostic, prognostic and predictive markers and technologies 5 Development of Treatments and Therapeutic Interventions Discovery and development of therapeutic interventions and testing in model systems and preclinical settings 6 Evaluation of Treatments and Therapeutic Interventions Testing and evaluation of therapeutic interventions in clinical, community or applied settings 7 Management of Diseases and Conditions Research into individual care needs and management of disease, conditions or ill health 8Health and Social Care Services Research Research into the provision and delivery of health and social care services, health policy and studies of research design, measurements and methodologies

Notes on Research Activity Codes (1)  1 Underpinning  normal / healthy / non-diseased  pain, immune responses, pregnancy, ageing, cell death DNA repair are considered normal  not just biological = chemistry, psychology, social  2 Aetiology  not just causation – describing development, progression and life course of disease  includes epidemiology and observational studies

Notes on Research Activity Codes (2)  3 Prevention  excludes secondary prevention (prevention of a condition recurring)  4 Detection and Diagnosis  markers / screening / monitoring / prediction  4.1 – pre-clinical / lab based  4.2 – clinical studies in humans  5 Treatment Development  pre-clinical / lab based - including patient samples

Notes on Research Activity Codes (3)  6 Treatment Evaluation  clinical studies in humans – including all therapeutic trials phases I-IV  includes economic evaluation and assessing quality of life as part of study measures  7 Disease Management  personal perspective – research into activities of health professionals and/or needs of patients  8 Health Services  institutional perspective – research into organisations and service delivery

Guidance Topics on Research Activity Codes See specific guidance on:  Repeated terms and concepts  Trials, policy, education, evaluation etc.  Methodology  Appears in 3 Groups  Resources and infrastructure  Appears in all 8 Groups

Approach to Coding  Identify main aim(s) and health focus(es) of research within lifetime of award  Allocate the minimum number of codes to reflect these  Assign equal percentages adding to 100% for both Health Categories and Research Activity Codes (unless there are clear reasons not to)  Example coding of one hypothetical award:  A clinical trial in humans to test a new drug therapy for treating lung cancer  6.1 Pharmaceuticals -> 100%  Cancer -> 100%

Rules For Assigning Health Categories  Identify the main health or disease focus(es) of the award  Ignore background work often listed as being relevant and future potential downstream outcomes  Match each to a Health Category obeying the specific inclusion criteria  e.g. “testing a treatment for lung cancer” -> Cancer not Respiratory  Knowledge of pathogenesis, symptoms and disease site may not always be relevant  Assign up to a maximum of 5 Health Categories  Generic Health Relevance should be assigned if more than 5 categories apply or there is wide health relevance  The Other category is only for very specific cases – do not use if you are uncertain  Special rules  studies of alcohol, diet, exercise and smoking  consequences or side effects of a pre-existing condition

Rules For Assigning Research Activity Codes  Identify the main aim(s) of the award  Ignore background work often listed as being relevant and future potential downstream outcomes  Match each to a Research Activity Code group  e.g. “a trial in humans testing a new therapy” -> 6 Treatment Evaluation  Note that HRCS code names and research concepts are repeated across code groups  e.g. trials are not always therapeutic trials  e.g. studies of therapies can be in humans or pre-clinical  Then select appropriate code from within group  e.g. “it is a drug trial” -> 6.1 Pharmaceuticals  Assign up to 2 Research Activity Codes (4 for large programmes)

Igniting our potential